Results for “ ”

Entry Author Date Location
On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO 07/06/20 San Francisco
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases 07/06/20 Boston
Moderna: Speed of COVID 19 Vaccine Hinges On Enrolling Right Patients 07/02/20 National
BioNTech’s mRNA COVID-19 Vaccine Shows Early Signs of Sparking Immunity 07/01/20 Europe
Amylyx Adds $30M to Press On With Neuro Drug for ALS, Alzheimer’s 07/01/20 Boston
Chiesi Licenses Bioasis Tech to Tackle Brain Symptoms of Rare Diseases 07/01/20 Boston
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later 06/30/20 Boston
FDA Says “No” to Intercept Pharma’s NASH Drug, Asks for More Data 06/29/20 New York
Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More 06/26/20 National
CSL Behring Bolsters Hemophilia Lineup With Deal for uniQure’s Gene Therapy 06/25/20 Philadelphia
Relay Lays $200M IPO Plan to Fund Tests of Protein Motion Cancer Drugs 06/25/20 Boston
La Jolla Pharma Steps In With Better Offer, Wins Tetraphase Bidding War 06/24/20 San Diego
Sarepta Inks Codiak Deal to Explore Combining Exosomes, Muscle Meds 06/22/20 Boston
Diversity & Inclusion Events Have Halted. Our Conversations Shouldn’t. 06/22/20 Boston
Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better 06/19/20 Raleigh Durham
Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More 06/19/20 National
In Microbiome Milestone, Finch Therapeutics C. diff Pill Bests Placebo 06/19/20 Boston
Engrail Therapeutics Launches With $32M to Develop New Neuro Drugs 06/18/20 San Diego
Orca Bio Surfaces With $192M and Recipes for “Custom” Cell Therapies 06/17/20 San Francisco
Frazier Launches Lassen to Advance Antibodies Against Fibrosis, Cancer 06/17/20 San Diego
C4 Therapeutics Adds $170M to Test Protein Degraders in the Clinic 06/16/20 Boston
GSK Expands Synthetic Lethality Scope With $120M Ideaya Bio Alliance 06/16/20 San Francisco
Akili Interactive’s Video Game for ADHD Gets the FDA All Clear 06/15/20 Boston
FDA Reverses Authorization for Use of Antimalarials to Treat COVID-19 06/15/20 National
GlaxoSmithKline Keeps Oncology 2.0 Growth Plans on Track 06/12/20 National
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Novo Nordisk Strikes a $725M Deal for AstraZeneca Spinout Corvidia 06/11/20 Boston
Moderna Finalizes Plan, Dose for Phase 3 Test of mRNA COVID Vaccine 06/11/20 Boston
Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes 06/11/20 Boston
Melinta Expands Antibiotics Lineup With $39M Tetraphase Acquisition 06/09/20 New York
Page 1 of 633 next page »